BRIEF-CM Life Sciences III Inc Says Melanie Nallicheri Has Been Appointed Chief Executive Officer Of Eqrx

Reuters2021-08-06

Aug 6 (Reuters) - CM Life Sciences III Inc :

* CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX

* CM LIFE SCIENCES III INC SAYS ALEXIS BORISY HAS BEEN APPOINTED EXECUTIVE CHAIRMAN OF EQRX'S BOARD OF DIRECTORS

* CM LIFE SCIENCES III INC - TRANSACTION IS EXPECTED TO PROVIDE UP TO $1.8 BILLION IN CASH PROCEEDS TO EQRX

* CM LIFE SCIENCES III INC - UPON CLOSING OF BUSINESS COMBINATION, CM LIFE SCIENCES III WILL BE RENAMED "EQRX, INC."

* CM LIFE SCIENCES III - UPON CLOSING, COMBINED CO'S COMMON STOCK, WARRANTS EXPECTED TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOLS "EQRX" & "EQRXW," RESPECTIVELY

* CM LIFE SCIENCES III INC - DEAL FINANCING INCLUDES FULLY COMMITTED PRIVATE PLACEMENT OF COMMON STOCK OF $1.2 BILLION AT $10.00 PER SHARE

* CM LIFE SCIENCES III - PIPE FROM INVESTORS, LED BY SB NORTHSTAR LP AND INCLUDING FUNDS ADVISED BY CASDIN CAPITAL AND CORVEX MANAGEMENT

* CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE FIDELITY MANAGEMENT & RESEARCH, FRANKLIN TEMPLETON ANDREESSEN HOROWITZ (A16Z)

* CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE ANDREESSEN HOROWITZ (A16Z), MUBADALA INVESTMENT & ASSET MANAGEMENT UNIT, MUBADALA CAPITAL, VERILY, OTHERS

* CM LIFE SCIENCES III - AS PART OF DEAL, EQRX STOCKHOLDERS WILL RECEIVE COMMON STOCK OF CM LIFE SCIENCES III IN EXCHANGE FOR SHARES OF EQRX

* CM LIFE SCIENCES III - DEAL VALUES EQRX AT PRE-TRANSACTION ENTERPRISE VALUE OF $3.65 BILLION WITH ADDITIONAL $500 MILLION POTENTIAL PERFORMANCE BASED EARNOUT

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2157324467?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-06 19:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2157324467","market":"us","top_or_hot":-1,"title":"BRIEF-CM Life Sciences III Inc Says Melanie Nallicheri Has Been Appointed Chief Executive Officer Of Eqrx","media":"Reuters","content":"<html><body><p>Aug 6 (Reuters) - <a href=\"https://laohu8.com/S/CMLT\">CM Life Sciences III Inc</a>   :</p><p>   * CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX</p><p>   * CM LIFE SCIENCES III INC SAYS ALEXIS BORISY HAS BEEN APPOINTED EXECUTIVE CHAIRMAN OF EQRX'S BOARD OF DIRECTORS</p><p>   * CM LIFE SCIENCES III INC - TRANSACTION IS EXPECTED TO PROVIDE UP TO $1.8 BILLION IN CASH PROCEEDS TO EQRX</p><p>   * CM LIFE SCIENCES III INC - UPON CLOSING OF BUSINESS COMBINATION, CM LIFE SCIENCES III WILL BE RENAMED \"EQRX, INC.\"</p><p>   * CM LIFE SCIENCES III - UPON CLOSING, COMBINED CO'S COMMON STOCK, WARRANTS EXPECTED TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOLS \"EQRX\" &amp; \"EQRXW,\" RESPECTIVELY</p><p>   * CM LIFE SCIENCES III INC - DEAL FINANCING INCLUDES FULLY COMMITTED PRIVATE PLACEMENT OF COMMON STOCK OF $1.2 BILLION AT $10.00 PER SHARE</p><p>   * CM LIFE SCIENCES III - PIPE FROM  INVESTORS, LED BY SB NORTHSTAR LP AND INCLUDING FUNDS ADVISED BY CASDIN CAPITAL AND CORVEX MANAGEMENT</p><p>   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE FIDELITY MANAGEMENT &amp; RESEARCH, FRANKLIN TEMPLETON ANDREESSEN HOROWITZ (A16Z)</p><p>   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE ANDREESSEN HOROWITZ (A16Z), MUBADALA INVESTMENT &amp; ASSET MANAGEMENT UNIT, MUBADALA CAPITAL, VERILY, OTHERS</p><p>   * CM LIFE SCIENCES III - AS PART OF DEAL, EQRX STOCKHOLDERS WILL RECEIVE COMMON STOCK OF CM LIFE SCIENCES III IN EXCHANGE FOR SHARES OF EQRX</p><p>   * CM LIFE SCIENCES III - DEAL VALUES EQRX AT PRE-TRANSACTION ENTERPRISE VALUE OF $3.65 BILLION WITH ADDITIONAL $500 MILLION POTENTIAL PERFORMANCE BASED EARNOUT</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-CM Life Sciences III Inc Says Melanie Nallicheri Has Been Appointed Chief Executive Officer Of Eqrx</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-CM Life Sciences III Inc Says Melanie Nallicheri Has Been Appointed Chief Executive Officer Of Eqrx\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-06 19:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 6 (Reuters) - <a href=\"https://laohu8.com/S/CMLT\">CM Life Sciences III Inc</a>   :</p><p>   * CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX</p><p>   * CM LIFE SCIENCES III INC SAYS ALEXIS BORISY HAS BEEN APPOINTED EXECUTIVE CHAIRMAN OF EQRX'S BOARD OF DIRECTORS</p><p>   * CM LIFE SCIENCES III INC - TRANSACTION IS EXPECTED TO PROVIDE UP TO $1.8 BILLION IN CASH PROCEEDS TO EQRX</p><p>   * CM LIFE SCIENCES III INC - UPON CLOSING OF BUSINESS COMBINATION, CM LIFE SCIENCES III WILL BE RENAMED \"EQRX, INC.\"</p><p>   * CM LIFE SCIENCES III - UPON CLOSING, COMBINED CO'S COMMON STOCK, WARRANTS EXPECTED TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOLS \"EQRX\" &amp; \"EQRXW,\" RESPECTIVELY</p><p>   * CM LIFE SCIENCES III INC - DEAL FINANCING INCLUDES FULLY COMMITTED PRIVATE PLACEMENT OF COMMON STOCK OF $1.2 BILLION AT $10.00 PER SHARE</p><p>   * CM LIFE SCIENCES III - PIPE FROM  INVESTORS, LED BY SB NORTHSTAR LP AND INCLUDING FUNDS ADVISED BY CASDIN CAPITAL AND CORVEX MANAGEMENT</p><p>   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE FIDELITY MANAGEMENT &amp; RESEARCH, FRANKLIN TEMPLETON ANDREESSEN HOROWITZ (A16Z)</p><p>   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE ANDREESSEN HOROWITZ (A16Z), MUBADALA INVESTMENT &amp; ASSET MANAGEMENT UNIT, MUBADALA CAPITAL, VERILY, OTHERS</p><p>   * CM LIFE SCIENCES III - AS PART OF DEAL, EQRX STOCKHOLDERS WILL RECEIVE COMMON STOCK OF CM LIFE SCIENCES III IN EXCHANGE FOR SHARES OF EQRX</p><p>   * CM LIFE SCIENCES III - DEAL VALUES EQRX AT PRE-TRANSACTION ENTERPRISE VALUE OF $3.65 BILLION WITH ADDITIONAL $500 MILLION POTENTIAL PERFORMANCE BASED EARNOUT</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGEM","symbol_name":"Cullinan Therapeutics","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2157324467","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2157324467","pubTimestamp":1628249236,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 6 (Reuters) - CM Life Sciences III Inc   :   * CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX   * CM LIFE SCIENCES III INC SAYS ALEXIS BORISY H","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGEM":"Cullinan Therapeutics","CMLFU":"CM Life Sciences, Inc.","LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","SANA":"Sana Biotechnology, Inc."},"translate_title":"简讯-CM生命科学III公司表示，梅勒妮·纳利切里已被任命为Eqrx的首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABP":1,"SANA":1,"CMLT":1,"CGEM":1,"CMIIU":1,"LHDX":1,"CMLFU":1,"APR":1,"CMLTU":1},"content_text":"Aug 6 (Reuters) - CM Life Sciences III Inc   :   * CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX   * CM LIFE SCIENCES III INC SAYS ALEXIS BORISY HAS BEEN APPOINTED EXECUTIVE CHAIRMAN OF EQRX'S BOARD OF DIRECTORS   * CM LIFE SCIENCES III INC - TRANSACTION IS EXPECTED TO PROVIDE UP TO $1.8 BILLION IN CASH PROCEEDS TO EQRX   * CM LIFE SCIENCES III INC - UPON CLOSING OF BUSINESS COMBINATION, CM LIFE SCIENCES III WILL BE RENAMED \"EQRX, INC.\"   * CM LIFE SCIENCES III - UPON CLOSING, COMBINED CO'S COMMON STOCK, WARRANTS EXPECTED TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOLS \"EQRX\" & \"EQRXW,\" RESPECTIVELY   * CM LIFE SCIENCES III INC - DEAL FINANCING INCLUDES FULLY COMMITTED PRIVATE PLACEMENT OF COMMON STOCK OF $1.2 BILLION AT $10.00 PER SHARE   * CM LIFE SCIENCES III - PIPE FROM  INVESTORS, LED BY SB NORTHSTAR LP AND INCLUDING FUNDS ADVISED BY CASDIN CAPITAL AND CORVEX MANAGEMENT   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE FIDELITY MANAGEMENT & RESEARCH, FRANKLIN TEMPLETON ANDREESSEN HOROWITZ (A16Z)   * CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE ANDREESSEN HOROWITZ (A16Z), MUBADALA INVESTMENT & ASSET MANAGEMENT UNIT, MUBADALA CAPITAL, VERILY, OTHERS   * CM LIFE SCIENCES III - AS PART OF DEAL, EQRX STOCKHOLDERS WILL RECEIVE COMMON STOCK OF CM LIFE SCIENCES III IN EXCHANGE FOR SHARES OF EQRX   * CM LIFE SCIENCES III - DEAL VALUES EQRX AT PRE-TRANSACTION ENTERPRISE VALUE OF $3.65 BILLION WITH ADDITIONAL $500 MILLION POTENTIAL PERFORMANCE BASED EARNOUTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2157324467","isCrawlerRequest":true}